This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;12(4):438-9.

doi: 10.3109/14653249.2010.499712.

Getting beneath the skin to understand MSC complexity

Massimo Dominici¹, Edwin M Horwitz

Affiliations

PMID: 20608761
DOI: 10.3109/14653249.2010.499712

Comment

Getting beneath the skin to understand MSC complexity

Massimo Dominici et al. Cytotherapy. 2010 Jul.

. 2010 Jul;12(4):438-9.

doi: 10.3109/14653249.2010.499712.

Authors

Massimo Dominici¹, Edwin M Horwitz

Affiliation

¹ Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy. massimo.dominici@unimore.it

PMID: 20608761
DOI: 10.3109/14653249.2010.499712

No abstract available

PubMed Disclaimer

Comment on

Proteomic analysis of human mesenchymal stromal cells derived from adipose tissue undergoing osteoblast differentiation.
Giusta MS, Andrade H, Santos AV, Castanheira P, Lamana L, Pimenta AM, Goes AM. Giusta MS, et al. Cytotherapy. 2010 Jul;12(4):478-90. doi: 10.3109/14653240903580270. Cytotherapy. 2010. PMID: 20230220
Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation.
Habisch HJ, Liebau S, Lenk T, Ludolph AC, Brenner R, Storch A. Habisch HJ, et al. Cytotherapy. 2010 Jul;12(4):491-504. doi: 10.3109/14653241003649502. Cytotherapy. 2010. PMID: 20331410

Similar articles

MSC: a coming of age in regenerative medicine.
Horwitz EM. Horwitz EM. Cytotherapy. 2006;8(3):194-5. doi: 10.1080/14653240600758562. Cytotherapy. 2006. PMID: 16793727 No abstract available.
Mesenchymal stromal cell migration: possibilities to improve cellular therapy.
Maijenburg MW, van der Schoot CE, Voermans C. Maijenburg MW, et al. Stem Cells Dev. 2012 Jan;21(1):19-29. doi: 10.1089/scd.2011.0270. Epub 2011 Aug 5. Stem Cells Dev. 2012. PMID: 21732817 Review.
A fat option for the pig: hepatocytic differentiated mesenchymal stem cells for translational research.
Brückner S, Tautenhahn HM, Winkler S, Stock P, Dollinger M, Christ B. Brückner S, et al. Exp Cell Res. 2014 Feb 15;321(2):267-75. doi: 10.1016/j.yexcr.2013.10.018. Epub 2013 Nov 4. Exp Cell Res. 2014. PMID: 24200501
Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine.
Charif N, Li YY, Targa L, Zhang L, Ye JS, Li YP, Stoltz JF, Han HZ, de Isla N. Charif N, et al. Biomed Mater Eng. 2017;28(s1):S57-S63. doi: 10.3233/BME-171624. Biomed Mater Eng. 2017. PMID: 28372278 Review.
Fate determination in mesenchymal stem cells: a perspective from histone-modifying enzymes.
Huang B, Li G, Jiang XH. Huang B, et al. Stem Cell Res Ther. 2015 Mar 19;6(1):35. doi: 10.1186/s13287-015-0018-0. Stem Cell Res Ther. 2015. PMID: 25890062 Free PMC article. Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science